These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35907102)
1. Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study. Shams-Eldin AN; Yafasova A; Faurschou M; Schou M; Sun G; Gislason GH; Torp-Pedersen C; Fosbøl EL; Køber L; Butt JH Clin Rheumatol; 2022 Nov; 41(11):3525-3536. PubMed ID: 35907102 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406 [TBL] [Abstract][Full Text] [Related]
3. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study. Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306 [TBL] [Abstract][Full Text] [Related]
4. Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Cutaneous Lupus Erythematosus: A Population-Based Cohort Study. Singh AG; Crowson CS; Singh S; Denis M; Davis P; Maradit-Kremers H; Matteson EL; Chowdhary VR Arthritis Care Res (Hoboken); 2016 Nov; 68(11):1664-1670. PubMed ID: 27015109 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus. Yafasova A; Fosbøl EL; Schou M; Baslund B; Faurschou M; Docherty KF; Jhund PS; McMurray JJV; Sun G; Kristensen SL; Torp-Pedersen C; Køber L; Butt JH J Am Coll Cardiol; 2021 Apr; 77(14):1717-1727. PubMed ID: 33832598 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study. Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617 [TBL] [Abstract][Full Text] [Related]
7. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study. Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Grönhagen CM; Fored CM; Granath F; Nyberg F Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study. Ahlehoff O; Wu JJ; Raunsø J; Kristensen SL; Khalid U; Kofoed K; Gislason G Lupus; 2017 Nov; 26(13):1435-1439. PubMed ID: 28618892 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study. Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538 [TBL] [Abstract][Full Text] [Related]
11. Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study. Hesselvig JH; Egeberg A; Kofoed K; Gislason G; Dreyer L Br J Dermatol; 2018 Nov; 179(5):1095-1101. PubMed ID: 29885269 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark. Petersen MP; Möller S; Bygum A; Voss A; Bliddal M Lupus; 2018 Aug; 27(9):1424-1430. PubMed ID: 29788808 [TBL] [Abstract][Full Text] [Related]
13. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus. Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672 [TBL] [Abstract][Full Text] [Related]
14. Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients. Masseran C; Perray L; Murat de Montai Q; Mathian A; Teboul A; Francès C; Arnaud L; Costedoat-Chalumeau N; Amoura Z; Courvoisier DS; Barbaud A; Chasset F J Am Acad Dermatol; 2024 Jun; 90(6):1210-1217. PubMed ID: 38301924 [TBL] [Abstract][Full Text] [Related]
15. Cancer risk in cutaneous lupus erythematosus: a population-based cohort study. Singh AG; Crowson CS; Singh S; Davis MD; Maradit-Kremers H; Matteson EL; Chowdhary VR Rheumatology (Oxford); 2016 Nov; 55(11):2009-2013. PubMed ID: 27520797 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of cancer among 3663 patients with cutaneous lupus erythematosus: a Swedish nationwide cohort study. Grönhagen CM; Fored CM; Granath F; Nyberg F Br J Dermatol; 2012 May; 166(5):1053-9. PubMed ID: 22175767 [TBL] [Abstract][Full Text] [Related]
17. Late-onset cutaneous lupus erythematosus patients have distinctive clinical features and demographics versus early-onset patients. Anderson SR; Hynan LS; Chong BF Lupus; 2022 Oct; 31(12):1523-1528. PubMed ID: 35995793 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States. Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985 [TBL] [Abstract][Full Text] [Related]